Perelel is a biotech company that offers supplements designed for various stages of a woman's reproductive life cycle.
Perelel has raised $27.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Perelel's investors include Prelude Growth Partners, Willow Growth Partners, Selva Ventures, Unilever Ventures, Ironwood Ventures.
Perelel is headquartered in Los Angeles, United States.
Perelel is a biotech company that offers supplements designed for various stages of a woman's reproductive life cycle.
Perelel is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Perelel — Funding & Investors." VCBacked, November 20, 2025, https://www.vcbacked.co/company/perelel. Accessed October 10, 2026.
VCBacked. (2025). Perelel — Funding & Investors. Retrieved October 10, 2026, from https://www.vcbacked.co/company/perelel
{{cite web |title=Perelel — Funding & Investors |url=https://www.vcbacked.co/company/perelel |website=VCBacked |access-date=October 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated